Target intelligence / Profile preview

DNAJC25-GNG10 readthrough protein (DNAJC25-GNG10)

Target
DNAJC25-GNG10
Molecular classification
Other (Readthrough chimeric protein), Heat shock protein-related (via DNAJC25 origin), G protein-related (via GNG10 origin)
01

Overview

The DNAJC25-GNG10 readthrough protein is a chimeric protein product formed by co-transcription of the adjacent human DNAJC25 and GNG10 genes[1][3][10]. The resulting mRNA transcript incorporates the first exon of DNAJC25—encoding a member of the Hsp40 (DnaJ) co-chaperone family—and the last two exons of GNG10, which codes for the gamma subunit 10 of heterotrimeric G-proteins[1][3][10]. The resulting protein thus contains the N-terminus derived from DNAJC25 and the C-terminus from GNG10[3]. This readthrough event is relatively rare and its biological significance, distinct from the individual parent proteins, is unclear; no established function or disease association is annotated for the chimeric protein[3][10]. The parental protein, DNAJC25, is primarily involved in protein folding and cellular proteostasis as a co-chaperone to Hsp70, with notable downregulation observed in hepatocellular carcinoma and possible tumor suppressor functions[2][5]. GNG10 is part of the G protein family involved in signal transduction, but its physiological and disease roles remain incompletely detailed and are not specifically attributed to the readthrough product[3][5]. No drugs are known to specifically interact with the DNAJC25-GNG10 readthrough protein, nor are there mechanisms of action, biomarker roles, or safety concerns specific to this fusion product[3][10]. This readthrough locus and the resulting protein are documented in gene annotation resources, but current evidence suggests no independent therapeutic, diagnostic, or biomarker status.

Other names
DNAJC25-GNG10 proteinDNAJC25-GNG10 readthrough transcript
02

Mechanism of action

None established

03

Biological functions

No firmly established function for the chimeric protein; parental roles include protein folding/chaperone co-factor (from DNAJC25) and potential involvement in G-protein signaling (from GNG10)
04

Disease associations

Other (No clinical or disease roles established for this readthrough—parent DNAJC25 may serve as a tumor suppressor, especially in liver cancer[2])

Beyond the preview

Go deeper on DNAJC25-GNG10 readthrough protein (DNAJC25-GNG10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNAJC25-GNG10 readthrough protein (DNAJC25-GNG10).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call